Net Profit Margin
since 2005
Calculation
Abiomed Inc., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income (loss)1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 13.23% | = | 100 | × | 136,505) | ÷ | 1,031,753) |
| Mar 31, 2021 | 26.61% | = | 100 | × | 225,525) | ÷ | 847,522) |
| Mar 31, 2020 | 24.14% | = | 100 | × | 203,009) | ÷ | 840,883) |
| Mar 31, 2019 | 33.66% | = | 100 | × | 259,016) | ÷ | 769,432) |
| Mar 31, 2018 | 18.89% | = | 100 | × | 112,170) | ÷ | 593,749) |
| Mar 31, 2017 | 11.70% | = | 100 | × | 52,116) | ÷ | 445,304) |
| Mar 31, 2016 | 11.58% | = | 100 | × | 38,147) | ÷ | 329,543) |
| Mar 31, 2015 | 49.36% | = | 100 | × | 113,688) | ÷ | 230,311) |
| Mar 31, 2014 | 4.00% | = | 100 | × | 7,351) | ÷ | 183,643) |
| Mar 31, 2013 | 9.50% | = | 100 | × | 15,014) | ÷ | 158,124) |
| Mar 31, 2012 | 1.18% | = | 100 | × | 1,495) | ÷ | 126,375) |
| Mar 31, 2011 | -11.62% | = | 100 | × | (11,755) | ÷ | 101,151) |
| Mar 31, 2010 | -22.19% | = | 100 | × | (19,024) | ÷ | 85,713) |
| Mar 31, 2009 | -43.16% | = | 100 | × | (31,597) | ÷ | 73,210) |
| Mar 31, 2008 | -69.44% | = | 100 | × | (40,930) | ÷ | 58,941) |
| Mar 31, 2007 | -55.05% | = | 100 | × | (27,881) | ÷ | 50,649) |
| Mar 31, 2006 | -67.44% | = | 100 | × | (29,449) | ÷ | 43,670) |
| Mar 31, 2005 | -6.13% | = | 100 | × | (2,342) | ÷ | 38,216) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The financial trajectory from 2005 to 2022 reflects a comprehensive evolution from a loss-making entity to a highly profitable enterprise, followed by a recent period of margin compression. The period is marked by an initial phase of significant deficits, a transition to profitability, a period of rapid margin expansion, and a subsequent decline in net efficiency.
- Phase of Operational Deficits (2005–2011)
- During the first seven years of the analyzed period, net profit margins remained consistently negative. The deepest deficit occurred in 2008, with a net profit margin of -69.44%. While revenue grew steadily from 38.2 million to 101.2 million during this window, expenses significantly outpaced income, although a trend of narrowing losses began to emerge after 2008, improving to -11.62% by 2011.
- Transition to Profitability (2012–2014)
- A pivotal shift occurred in 2012, marking the first instance of positive net income with a profit margin of 1.18%. This initial profitability phase was characterized by volatility, with the margin rising to 9.50% in 2013 before retreating to 4.00% in 2014, suggesting a period of stabilization as the business model scaled.
- Accelerated Margin Expansion (2015–2019)
- A period of substantial growth in profitability was observed between 2015 and 2019. A notable peak occurred in 2015 with a net profit margin of 49.36%. Following a correction in 2016, margins climbed steadily from 11.58% to 33.66% by 2019. This growth coincided with a rapid increase in revenue, which rose from 230.3 million to 769.4 million, indicating strong operating leverage.
- Recent Performance and Margin Compression (2020–2022)
- In the final three years, profitability remained positive but experienced a downward trend. After maintaining margins between 24.14% and 26.61% in 2020 and 2021, a significant contraction occurred in 2022. Despite reaching a record revenue high of 1.03 billion, the net profit margin declined to 13.23%, the lowest level since 2014, reflecting a sharp increase in costs relative to revenue growth.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Abiomed Inc., net profit margin, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | 13.23% | 15.88% | 3.87% | 21.25% | 15.90% | 6.25% |
| Mar 31, 2021 | 26.61% | 16.42% | 4.46% | 29.85% | 11.97% | 6.06% |
| Mar 31, 2020 | 24.14% | 12.99% | 3.78% | 24.33% | 16.56% | 6.03% |
| Mar 31, 2019 | 33.66% | 11.56% | 4.66% | 30.80% | 15.16% | 5.76% |
| Mar 31, 2018 | 18.89% | 7.74% | 4.11% | 30.29% | 10.36% | 5.33% |
| Mar 31, 2017 | 11.70% | 1.74% | 4.31% | 21.09% | 13.56% | 5.28% |
| Mar 31, 2016 | 11.58% | 6.71% | 2.93% | 27.21% | 12.27% | 3.81% |
| Mar 31, 2015 | 49.36% | 21.68% | 3.27% | 24.69% | 13.20% | 3.72% |
| Mar 31, 2014 | 4.00% | 11.28% | 3.52% | 19.65% | 18.02% | 4.33% |
| Mar 31, 2013 | 9.50% | 11.79% | 3.55% | 29.62% | 20.90% | 4.62% |
| Mar 31, 2012 | 1.18% | 14.95% | 4.37% | 30.14% | 22.35% | 5.03% |
| Mar 31, 2011 | -11.62% | 12.17% | 4.42% | 28.17% | 19.43% | 5.08% |
| Mar 31, 2010 | -22.19% | 13.15% | 4.99% | 27.02% | 19.59% | 4.95% |
| Mar 31, 2009 | -43.16% | 18.68% | 7.80% | 22.11% | 14.86% | 4.42% |
| Mar 31, 2008 | -69.44% | 16.53% | 4.04% | 23.35% | 16.51% | 3.70% |
| Mar 31, 2007 | -55.05% | 13.92% | 5.56% | 24.06% | 22.78% | 6.26% |
| Mar 31, 2006 | -67.44% | 7.64% | 5.52% | 19.33% | 22.55% | 5.89% |
| Mar 31, 2005 | -6.13% | 15.10% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 13.23% | 7.05% |
| Mar 31, 2021 | 26.61% | 7.14% |
| Mar 31, 2020 | 24.14% | 6.82% |
| Mar 31, 2019 | 33.66% | 6.91% |
| Mar 31, 2018 | 18.89% | 5.87% |
| Mar 31, 2017 | 11.70% | 5.60% |
| Mar 31, 2016 | 11.58% | 4.73% |
| Mar 31, 2015 | 49.36% | 5.78% |
| Mar 31, 2014 | 4.00% | 5.76% |
| Mar 31, 2013 | 9.50% | 6.37% |
| Mar 31, 2012 | 1.18% | 8.05% |
| Mar 31, 2011 | -11.62% | 7.40% |
| Mar 31, 2010 | -22.19% | 7.67% |
| Mar 31, 2009 | -43.16% | 8.63% |
| Mar 31, 2008 | -69.44% | 6.88% |
| Mar 31, 2007 | -55.05% | 8.40% |
| Mar 31, 2006 | -67.44% | 7.20% |
| Mar 31, 2005 | -6.13% | 9.04% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., net profit margin, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 13.23% | 14.65% |
| Mar 31, 2021 | 26.61% | 15.24% |
| Mar 31, 2020 | 24.14% | 10.27% |
| Mar 31, 2019 | 33.66% | 14.56% |
| Mar 31, 2018 | 18.89% | 12.61% |
| Mar 31, 2017 | 11.70% | 9.26% |
| Mar 31, 2016 | 11.58% | 12.80% |
| Mar 31, 2015 | 49.36% | 13.94% |
| Mar 31, 2014 | 4.00% | 14.40% |
| Mar 31, 2013 | 9.50% | 15.04% |
| Mar 31, 2012 | 1.18% | 13.92% |
| Mar 31, 2011 | -11.62% | 12.06% |
| Mar 31, 2010 | -22.19% | 11.90% |
| Mar 31, 2009 | -43.16% | 17.77% |
| Mar 31, 2008 | -69.44% | 13.00% |
| Mar 31, 2007 | -55.05% | 12.52% |
| Mar 31, 2006 | -67.44% | 15.30% |
| Mar 31, 2005 | -6.13% | 14.61% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).